-transparent.png){kind=logo}
1,3-butadiene (CAS No. 106-99-0) was evaluated for carcinogenicity and chronic toxicity by inhalation exposure in B6C3F1 mice because of its high production volume, widespread exposure of workers, and the lack of carcinogenicity and toxicity data (NTP Report #228, 1984). Butadiene (BD) had long been considered to have low toxicity. The long-term studies established that BD is a potent mouse carcinogen with multiple organ carcinogenicity (Huff et al. 1985; Melnick et al. 1988). This paper presents morphological descriptions and illustrations of the neoplastic lesions induced by 1,3-butadiene in B6C3F1 mice.
Related Publications
R A Miller, and
R L Melnick, and
G A Boorman
June 1990,
Environmental health perspectives,
R A Miller, and
R L Melnick, and
G A Boorman
January 1988,
Toxicologic pathology,
R A Miller, and
R L Melnick, and
G A Boorman
July 1996,
Cancer research,
R A Miller, and
R L Melnick, and
G A Boorman
December 1996,
Toxicology and applied pharmacology,
R A Miller, and
R L Melnick, and
G A Boorman
January 1989,
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,
R A Miller, and
R L Melnick, and
G A Boorman
January 2005,
Toxicologic pathology,
R A Miller, and
R L Melnick, and
G A Boorman
January 1987,
Environmental mutagenesis,
R A Miller, and
R L Melnick, and
G A Boorman
March 1986,
Toxicology and applied pharmacology,
R A Miller, and
R L Melnick, and
G A Boorman
February 1986,
Experimental and molecular pathology,
R A Miller, and
R L Melnick, and
G A Boorman
March 2009,
Cancer research,
